OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Sanofi/  FR0000120578  /

Cboe Europe DXE
9/22/2023  5:35:15 PM Chg. -0.56 Volume Bid5:35:15 PM Ask5:36:30 PM Market Capitalization Dividend Y. P/E Ratio
101.98EUR -0.55% 679,786
Turnover: 25.14 mill.		 -Bid Size: - -Ask Size: - 127.82 bill.EUR 3.49% 15.26
TeleTrader 7/28 Sanofi's EPS up 22% to €1.15 in Q2
TeleTrader 7/17 AstraZeneca-Sanofi RSV shot for children approved by FDA
TeleTrader 6/29 Sanofi expects to top $10B in annual vaccine sales by 2030
TeleTrader 4/27 Sanofi's Q1 net sales up 5.5% to €10.22 billion
TeleTrader 4/21 Drug firms CEOs to testify on insulin prices in Senate
TeleTrader 3/13 Sanofi to acquire Provention Bio for $2.9 billion
TeleTrader 2/3 Sanofi Q4 net sales up 7.3% to €10.73 billion
TeleTrader 1/13 J&J reportedly cuts COVID vaccine production
TeleTrader 12/12/2022 Amgen to buy Horizon for $26.4 billion
TeleTrader 12/11/2022 Amgen close to buying Horizon, worth over $20B - report
TeleTrader 12/7/2022 Sanofi, GSK surge as court dismisses Zantac suits
TeleTrader 11/10/2022 EU approves Sanofi-GSK booster COVID jab
TeleTrader 10/28/2022 Sanofi: Q3 net sales up 20% to €12.48 billion
TeleTrader 9/5/2022 SocGen CEO to become Sanofi's non-executive chairman
TeleTrader 8/11/2022 GSK falls 12% on worries over Zantac litigation
TeleTrader 7/28/2022 Sanofi's Q2 sales up by 15.7% to €10.12B
TeleTrader 6/24/2022 Sanofi: COVID shot has 72% Omicron efficacy
TeleTrader 6/2/2022 Regeneron to buy Sanofi's stake in joint project for $900M
TeleTrader 4/28/2022 Sanofi's revenue rises 12.6% to €9.7B in Q1
TeleTrader 3/30/2022 EMA begins reviewing Sanofi-GSK COVID-19 vaccine
GlobeNewswire 3/30/2022 Press Release: Availability of the Q1 2022 Memorandum for modelling purposes
GlobeNewswire 3/29/2022 IGM Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate...
GlobeNewswire 3/29/2022 IGM Biosciences to Host Conference Call and Webcast Today to Discuss Global Collaboration Agreement ...
GlobeNewswire 3/29/2022 Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology ...
GlobeNewswire 3/29/2022 Press Release: Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilum...